Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 2,070,092	$ 34,364,346
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(314,042)	138,587
Other-than-temporary impairments	(0)	5,000,000
Realized investment gains, net	(9,463,843)	(14,168,911)
Change in fair value of equity securities	3,830,793	(33,690,712)
Unrealized trading losses included in income	0	1,086
Realized trading losses included in income	0	12,197
Amortization of cost of insurance acquired	661,257	688,348
Provision for deferred income tax expense	372,861	2,517,685
Depreciation and depletion	728,887	2,032,627
Stock-based compensation	801,812	599,192
Charges for mortality and administration of universal life and annuity products	(5,692,118)	(5,943,417)
Interest credited to account balances	3,646,515	3,767,177
Change in accrued investment income	(629,387)	(107,518)
Change in reinsurance receivables	374,689	210,672
Change in policy liabilities and accruals	(3,535,674)	(2,836,498)
Change in income taxes receivable (payable)	(6,317,108)	5,164,454
Change in other assets and liabilities, net	3,679,893	(3,083,634)
Net cash used in operating activities	(9,785,373)	(5,334,319)
Proceeds from investments sold and matured:
Fixed maturities available for sale	7,558,333	13,128,136
Equity securities	7,838,385	36,126,454
Trading securities	0	17,983
Mortgage loans	17,770,810	3,655,779
Real estate	16,531,219	12,659,854
Notes receivable	4,944,143	12,329,505
Policy loans	1,453,634	1,752,613
Short-term investments	23,490,815	0
Total proceeds from investments sold and matured	79,587,339	79,670,324
Cost of investments acquired:
Fixed maturities available for sale	0	(2,614,165)
Equity securities	(12,454,268)	(27,523,161)
Trading securities	0	(32,382)
Mortgage loans	(2,654,293)	(5,158,911)
Real estate	(3,417,744)	(4,586,280)	[1]
Notes receivable	(4,779,241)	(9,030,657)
Policy loans	(904,446)	(929,549)
Short-term investments	(48,473,476)	(3,591,885)
Total cost of investments acquired	(72,683,468)	(53,466,990)
Net cash provided by investing activities	6,903,871	26,203,334
Cash flows from financing activities:
Policyholder contract deposits	4,056,116	4,555,115
Policyholder contract withdrawals	(4,294,297)	(5,106,391)
Proceeds from notes payable/line of credit	21,500,000	58,500,000
Payments of principal on notes payable/line of credit	(21,500,000)	(63,500,000)
Purchase of treasury stock	(881,966)	(685,808)
Noncontrolling contributions/(distributions) of consolidated subsidiary	(103,540)	(128,824)
Net cash used in financing activities	(1,223,687)	(6,365,908)
Net increase (decrease) in cash and cash equivalents	(4,105,189)	14,503,107
Cash and cash equivalents at beginning of year	45,290,385	30,787,278
Cash and cash equivalents at end of year	$ 41,185,196	$ 45,290,385

[1] The Company has elected to reclassify certain investments to conform with the presentation for the year ended December 31, 2023. These reclassifications had no impact on previously reported net income.